GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women.
about
BMI and BMD: The Potential Interplay between Obesity and Bone FragilityLong-term Effects of Antihypertensive Drug Use and New-onset Osteoporotic Fracture in Elderly Patients: A Population-based Longitudinal Cohort StudyThe Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms.Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and PharmacodynamicsEffect of Intravenous Glucose Tolerance Test on Bone Turnover Markers in Adults with Normal Glucose Tolerance.Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health.Pathophysiology of Bone Fragility in Patients with Diabetes.Insulin resistance and bone: a biological partnership.Complex interplay among adiposity, insulin resistance and bone health.Structure and Function of Bone Marrow Adipocytes.Liraglutide exerts a bone-protective effect in ovariectomized rats with streptozotocin-induced diabetes by inhibiting osteoclastogenesis.Centrally Acting Agents for Obesity: Past, Present, and FutureWeight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levelsSkeletal Fragility in Type 2 Diabetes Mellitus
P2860
Q26744811-67013826-E0DA-4DFF-8BE9-B99D37A9CF85Q28468516-D9B56E9A-E7C8-4292-B84D-6E6FAFE28299Q33627749-0936A42F-6695-4045-9FB4-98B96B738950Q36924102-B52CCC3F-E4A8-428B-BD75-52AC51D95FE2Q37142475-A6163011-9521-42DB-8182-D3BC8C0C65C8Q38973384-5BA49993-1DB9-4D5B-9C65-CEFAB01BC2E9Q39127683-4722DEAE-166E-4247-847F-4016457CE284Q48245873-EB6B5511-E11A-4D34-89C1-CF7AA8DB560FQ50044972-C0398B40-92FE-4E69-A936-8686D7040A25Q52709053-FA91CFE6-F5B1-4640-8AAB-9927E14B8507Q55049594-F2B8B55F-5DE4-4EA9-B022-DB9AF2CEDA35Q57177981-B51F2FE9-35AA-4C67-999D-63EC8B280D55Q57655866-A5836F93-5B8A-4B26-81D0-C41853578CEBQ58725004-CD696E25-10B0-4BE0-BED6-D506524BADB8
P2860
GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
GLP-1 Receptor Agonist Treatme ...... in Weight-Reduced Obese Women.
@ast
GLP-1 Receptor Agonist Treatme ...... in Weight-Reduced Obese Women.
@en
type
label
GLP-1 Receptor Agonist Treatme ...... in Weight-Reduced Obese Women.
@ast
GLP-1 Receptor Agonist Treatme ...... in Weight-Reduced Obese Women.
@en
prefLabel
GLP-1 Receptor Agonist Treatme ...... in Weight-Reduced Obese Women.
@ast
GLP-1 Receptor Agonist Treatme ...... in Weight-Reduced Obese Women.
@en
P50
P356
P1476
GLP-1 Receptor Agonist Treatme ...... in Weight-Reduced Obese Women.
@en
P304
P356
10.1210/JC.2015-1176
P407
P50
P577
2015-06-04T00:00:00Z